Sativex approved by the Spanish regulator

Wednesday 28 July 2010

A cannabis medicine developed by GW Pharmaceuticals Plc for the treatment of spasticity due to multiple sclerosis has been approved by the Spanish regulator. This follows its approval in June, 2010, by the UK regulator, the MHRA.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom